(Refiles to remove extraneous text in headline)
SINGAPORE, Oct 10 (Reuters) - Religare Health Trust willraise S$511 million ($416 million) after pricing its initialpublic share offer in Singapore below the middle of anindicative range, two sources with direct knowledge of thematter said on Wednesday.
The deal was priced at S$0.90 per unit, which compared witha price range of S$0.88 to S$0.97 given in a prospectus lastmonth, the sources said.
Religare Health, which is structured as a business trust,has a mandate to invest in medical and healthcare assets andservices in Asia, Australasia and emerging markets and will ownhospital-related assets managed by India-listed group FortisHealthcare Ltd .
The final price indicates a prospective dividend yield of8.95 percent, one of the sources said.
CIMB , DBS , Nomura Holdings ,Religare Capital Markets and Standard Chartered arejoint bookrunners for the IPO with Citigroup as joint leadmanager.
($1=1.2293 Singapore dollars)
(Reporting by Saeed Azhar; Editing by Greg Mahlich)
Keywords: RELIGARE IPO/